EHA 2026 | Entrevista con el profesor Wang Liang del Hospital Tongren de Beijing, Universidad Médica Capital: La terapia CAR-T de doble objetivo CD19/CD22 supone un nuevo avance para el linfoma de células B grandes recidivante/refractario – MedSci
EHA 2026 | 专访首都医科大学附属北京同仁医院王亮教授：CD19/CD22 双靶点 CAR-T 为复发/难治大 B 细胞淋巴瘤带来新突破 梅斯医学 MedSci
Contenido completo del articulo
{{ if item. readStatus! = 1 }} {{/if}} {{ if item. readStatus == 1 }} {{/if}} {{ if item. hrefUrl }} {{item. messageTitle}} {{else}} {{item. messageTitle}} {{/if}} {{ if item. hrefUrl || {{item. messageContent. length < 60}} Expandir {{else}} Expandir {{/if}} Contraer {{ if item. hrefUrl }} {{item. messageContent}} {{else}} {{item. messageContent}} {{/if}} {{ item. cardName }} {{if item. expired}} Caducado {{else}} {{ item. endTime. split(' ') }} Caducado {{/if}} {{if item. expired}} {{else}} {{if item. propertyName == 'Membresía del curso'}} {{else}} {{/if}} {{/if}} {{if item. expired}} {{else}} {{/if}}
Câu hỏi thường gặp
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
